Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Agilent buys gene regulation analysis expert

This article was originally published in Clinica

Executive Summary

Agilent Technologies hopes to reach 10% of the microarray market by 2007, an undertaking that will be supported by its acquisition of Cambridge, Massachusetts-based Computational Biology, an expert in analysing gene regulation data generated by microarray experiments, writes Stefan Fritsch*. The annual microarray market is estimated by Instrumenta at $600m with an annual growth rate of 13-15%. Affymetrix still dominates with a market share of close to 70%. On the basis of these estimates, the market could be worth $1bn by 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054064

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel